VINC

Vincerx Pharma, Inc. Common Stock
VINC

Overview Fund Activity
Delisted

VINC was delisted on the 22nd of April, 2025.

Back to rankings

22 hedge funds and large institutions have $1.26M invested in Vincerx Pharma, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
-6
Holders Change %
-21.43%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$24.4K
2
HF
2
HRT Financial
New York
$15K
3
Focus Partners Wealth
3
Focus Partners Wealth
Massachusetts
$2.87K
4
Morgan Stanley
4
Morgan Stanley
New York
$549
5
Bank of America
5
Bank of America
North Carolina
$62

Top Sellers

1
PM
1
Prosight Management
Texas
$0
2
AC
2
Armistice Capital
New York
$149K
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
ECM
4
ExodusPoint Capital Management
New York
$0
5
Marshall Wace
5
Marshall Wace
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Marshall Wace
26
Marshall Wace
United Kingdom
– -$255K -17,678 Closed
XT
27
XTX Topco
Cayman Islands
– -$13.1K -916 Closed
Two Sigma Investments
28
Two Sigma Investments
New York
– -$10.2K -711 Closed
HCM
29
Hollencrest Capital Management
California
– -$7.16K -500 Closed
TRCT
30
Tower Research Capital (TRC)
New York
– -$5K -349 Closed
1
2